Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Phensuximide

An antiepileptic of the succinimide class, first described in 1951 and used for absence (petit mal) seizures; within the same family, ethosuximide later became the reference drug. This family brings together the active ingredient.

Did you know?In 2025 a study found that it blocks the enzyme RIPK1, involved in an inflammatory form of programmed cell death called necroptosis: a possible new use, seen in cells and laboratory mice.

PhensuximideGo to the active ingredient →
PhensuximideActive ingredientPhensuximideCat. No. P-P087-001CAS 86-34-0

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.